EPISODE · May 20, 2021 · 23 MIN
CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust
from HBR IdeaCast
Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic researchers to promote broader improvements to the healthcare system. She speaks with HBR's Editor-in-Chief Adi Ignatius about tackling challenges in an emerging industry.
Embed this episode
NOW PLAYING
CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust
No transcript for this episode yet
Similar Episodes
No similar episodes found.